首页>
外国专利>
BIOMARKERS FOR DISEASE ACTIVITY AND CLINICAL MANIFESTATIONS SYSTEMIC LUPUS ERYTHEMATOSUS
BIOMARKERS FOR DISEASE ACTIVITY AND CLINICAL MANIFESTATIONS SYSTEMIC LUPUS ERYTHEMATOSUS
展开▼
机译:疾病活动的生物标记物和临床表现系统性红斑狼疮
展开▼
页面导航
摘要
著录项
相似文献
摘要
This invention related to methods and assays for screening for, identifying, and predicting the severity and clinical manifestations of systemic lupus erythematosus (SLE). Specifically, this invention provides various biomarkers for the prediction of flares of the disease both in number and severity, as well as clinical manifestations of the disease, and methods of using these biomarkers to correctly subclassify patients with this disease, and prescribe appropriate treatment. The invention also provides for biomarkers of lupus disease activity, i.e., flares, as well as biomarkers for the prediction of future flares, and methods of using these biomarkers. The invention also provides, in these biomarkers, targets and methods for drug development and basic research for SLE.
展开▼